Cadaveric fascia lata pubovaginal slings

Early results on safety, efficacy and patient satisfaction

I. K. Walsh, T. Nambirajan, S. M. Donellan, V. Mahendra, Anthony R Stone

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To prospectively evaluate and quantify the efficacy of cadaveric fascia lata (CFL) as an allograft material in pubovaginal sling placement to treat stress urinary incontinence (SUI). Patients and methods: Thirty-one women with SUI (25 type II and six type III; mean age 63 years, range 40-75) had a CFL pubovaginal sling placed transvaginally. The operative time, blood loss, surgical complications and mean hospital stay were all documented. Before and at 4 months and 1 year after surgery each patient completed a 3-day voiding diary and validated voiding questionnaires (functional inquiry into voiding habits, Urogenital Distress Inventory and Incontinence Impact Questionnaire, including visual analogue scales). Results: The mean (range) operative time was 71 (50-120) min, blood loss 78.7 (20-250) mL and hospital stay 1.2 (1-2) days; there were no surgical complications. Over the mean follow-up of 13.5 months, complete resolution of SUI was reported by 29 (93%) patients. Overactive bladder symptoms were present in 23 (74%) patients before surgery, 21 (68%) at 4 months and two (6%) at 1 year; 80% of patients with low (< 15 cmH2 O) voiding pressures before surgery required self-catheterization afterward, as did 36% at 4 months, but only one (3%) at 1 year. Twenty-four (77%) patients needed to adopt specific postures to facilitate voiding. After surgery there was a significant reduction in daytime frequency, leakage episodes and pad use (P < 0.05). The severity of leak and storage symptoms was also significantly less (P < 0.002), whilst the severity of obstructive symptoms remained unchanged. Mean subjective levels of improvement were 69% at 4 months and 85% at 1 year, with corresponding objective satisfaction levels of 61% and 69%, respectively. At 1 year, ≈ 80% of the patients said they would undergo the procedure again and/or recommend it to a friend. Conclusion: Placing a pubovaginal sling of CFL allograft is a highly effective, safe surgical approach for resolving SUI, with a short operative time and rapid recovery. Storage symptoms are significantly improved, and subjective improvement and satisfaction rates are high.

Original languageEnglish (US)
Pages (from-to)415-419
Number of pages5
JournalBJU International
Volume90
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Fascia Lata
Patient Satisfaction
Stress Urinary Incontinence
Safety
Operative Time
Allografts
Length of Stay
Surgical Blood Loss
Overactive Urinary Bladder
Posture
Visual Analog Scale
Catheterization
Habits
Pressure
Equipment and Supplies

Keywords

  • Cadaveric fascia lata
  • Pubovaginal sling
  • Urinary incontinence

ASJC Scopus subject areas

  • Urology

Cite this

Cadaveric fascia lata pubovaginal slings : Early results on safety, efficacy and patient satisfaction. / Walsh, I. K.; Nambirajan, T.; Donellan, S. M.; Mahendra, V.; Stone, Anthony R.

In: BJU International, Vol. 90, No. 4, 2002, p. 415-419.

Research output: Contribution to journalArticle

Walsh, I. K. ; Nambirajan, T. ; Donellan, S. M. ; Mahendra, V. ; Stone, Anthony R. / Cadaveric fascia lata pubovaginal slings : Early results on safety, efficacy and patient satisfaction. In: BJU International. 2002 ; Vol. 90, No. 4. pp. 415-419.
@article{72d565a62df046858f10e4288639f681,
title = "Cadaveric fascia lata pubovaginal slings: Early results on safety, efficacy and patient satisfaction",
abstract = "Objective: To prospectively evaluate and quantify the efficacy of cadaveric fascia lata (CFL) as an allograft material in pubovaginal sling placement to treat stress urinary incontinence (SUI). Patients and methods: Thirty-one women with SUI (25 type II and six type III; mean age 63 years, range 40-75) had a CFL pubovaginal sling placed transvaginally. The operative time, blood loss, surgical complications and mean hospital stay were all documented. Before and at 4 months and 1 year after surgery each patient completed a 3-day voiding diary and validated voiding questionnaires (functional inquiry into voiding habits, Urogenital Distress Inventory and Incontinence Impact Questionnaire, including visual analogue scales). Results: The mean (range) operative time was 71 (50-120) min, blood loss 78.7 (20-250) mL and hospital stay 1.2 (1-2) days; there were no surgical complications. Over the mean follow-up of 13.5 months, complete resolution of SUI was reported by 29 (93{\%}) patients. Overactive bladder symptoms were present in 23 (74{\%}) patients before surgery, 21 (68{\%}) at 4 months and two (6{\%}) at 1 year; 80{\%} of patients with low (< 15 cmH2 O) voiding pressures before surgery required self-catheterization afterward, as did 36{\%} at 4 months, but only one (3{\%}) at 1 year. Twenty-four (77{\%}) patients needed to adopt specific postures to facilitate voiding. After surgery there was a significant reduction in daytime frequency, leakage episodes and pad use (P < 0.05). The severity of leak and storage symptoms was also significantly less (P < 0.002), whilst the severity of obstructive symptoms remained unchanged. Mean subjective levels of improvement were 69{\%} at 4 months and 85{\%} at 1 year, with corresponding objective satisfaction levels of 61{\%} and 69{\%}, respectively. At 1 year, ≈ 80{\%} of the patients said they would undergo the procedure again and/or recommend it to a friend. Conclusion: Placing a pubovaginal sling of CFL allograft is a highly effective, safe surgical approach for resolving SUI, with a short operative time and rapid recovery. Storage symptoms are significantly improved, and subjective improvement and satisfaction rates are high.",
keywords = "Cadaveric fascia lata, Pubovaginal sling, Urinary incontinence",
author = "Walsh, {I. K.} and T. Nambirajan and Donellan, {S. M.} and V. Mahendra and Stone, {Anthony R}",
year = "2002",
doi = "10.1046/j.1464-410X.2002.02913.x",
language = "English (US)",
volume = "90",
pages = "415--419",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Cadaveric fascia lata pubovaginal slings

T2 - Early results on safety, efficacy and patient satisfaction

AU - Walsh, I. K.

AU - Nambirajan, T.

AU - Donellan, S. M.

AU - Mahendra, V.

AU - Stone, Anthony R

PY - 2002

Y1 - 2002

N2 - Objective: To prospectively evaluate and quantify the efficacy of cadaveric fascia lata (CFL) as an allograft material in pubovaginal sling placement to treat stress urinary incontinence (SUI). Patients and methods: Thirty-one women with SUI (25 type II and six type III; mean age 63 years, range 40-75) had a CFL pubovaginal sling placed transvaginally. The operative time, blood loss, surgical complications and mean hospital stay were all documented. Before and at 4 months and 1 year after surgery each patient completed a 3-day voiding diary and validated voiding questionnaires (functional inquiry into voiding habits, Urogenital Distress Inventory and Incontinence Impact Questionnaire, including visual analogue scales). Results: The mean (range) operative time was 71 (50-120) min, blood loss 78.7 (20-250) mL and hospital stay 1.2 (1-2) days; there were no surgical complications. Over the mean follow-up of 13.5 months, complete resolution of SUI was reported by 29 (93%) patients. Overactive bladder symptoms were present in 23 (74%) patients before surgery, 21 (68%) at 4 months and two (6%) at 1 year; 80% of patients with low (< 15 cmH2 O) voiding pressures before surgery required self-catheterization afterward, as did 36% at 4 months, but only one (3%) at 1 year. Twenty-four (77%) patients needed to adopt specific postures to facilitate voiding. After surgery there was a significant reduction in daytime frequency, leakage episodes and pad use (P < 0.05). The severity of leak and storage symptoms was also significantly less (P < 0.002), whilst the severity of obstructive symptoms remained unchanged. Mean subjective levels of improvement were 69% at 4 months and 85% at 1 year, with corresponding objective satisfaction levels of 61% and 69%, respectively. At 1 year, ≈ 80% of the patients said they would undergo the procedure again and/or recommend it to a friend. Conclusion: Placing a pubovaginal sling of CFL allograft is a highly effective, safe surgical approach for resolving SUI, with a short operative time and rapid recovery. Storage symptoms are significantly improved, and subjective improvement and satisfaction rates are high.

AB - Objective: To prospectively evaluate and quantify the efficacy of cadaveric fascia lata (CFL) as an allograft material in pubovaginal sling placement to treat stress urinary incontinence (SUI). Patients and methods: Thirty-one women with SUI (25 type II and six type III; mean age 63 years, range 40-75) had a CFL pubovaginal sling placed transvaginally. The operative time, blood loss, surgical complications and mean hospital stay were all documented. Before and at 4 months and 1 year after surgery each patient completed a 3-day voiding diary and validated voiding questionnaires (functional inquiry into voiding habits, Urogenital Distress Inventory and Incontinence Impact Questionnaire, including visual analogue scales). Results: The mean (range) operative time was 71 (50-120) min, blood loss 78.7 (20-250) mL and hospital stay 1.2 (1-2) days; there were no surgical complications. Over the mean follow-up of 13.5 months, complete resolution of SUI was reported by 29 (93%) patients. Overactive bladder symptoms were present in 23 (74%) patients before surgery, 21 (68%) at 4 months and two (6%) at 1 year; 80% of patients with low (< 15 cmH2 O) voiding pressures before surgery required self-catheterization afterward, as did 36% at 4 months, but only one (3%) at 1 year. Twenty-four (77%) patients needed to adopt specific postures to facilitate voiding. After surgery there was a significant reduction in daytime frequency, leakage episodes and pad use (P < 0.05). The severity of leak and storage symptoms was also significantly less (P < 0.002), whilst the severity of obstructive symptoms remained unchanged. Mean subjective levels of improvement were 69% at 4 months and 85% at 1 year, with corresponding objective satisfaction levels of 61% and 69%, respectively. At 1 year, ≈ 80% of the patients said they would undergo the procedure again and/or recommend it to a friend. Conclusion: Placing a pubovaginal sling of CFL allograft is a highly effective, safe surgical approach for resolving SUI, with a short operative time and rapid recovery. Storage symptoms are significantly improved, and subjective improvement and satisfaction rates are high.

KW - Cadaveric fascia lata

KW - Pubovaginal sling

KW - Urinary incontinence

UR - http://www.scopus.com/inward/record.url?scp=0036965750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036965750&partnerID=8YFLogxK

U2 - 10.1046/j.1464-410X.2002.02913.x

DO - 10.1046/j.1464-410X.2002.02913.x

M3 - Article

VL - 90

SP - 415

EP - 419

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 4

ER -